Home Health News Kenya vaccine plant plans halt following $1 billion loss

Kenya vaccine plant plans halt following $1 billion loss

0
NAFDAC Approves Yse Of Moderna, Sputnik COVID-19 Vaccines

Moderna, a US pharmaceutical company, has halted plans to build a vaccine manufacturing facility in Kenya due to over $1 billion in losses from decreased demand for COVID-19 vaccines in Africa. Kenya vaccine plant plans halt following $1 billion loss

The decision comes after facing over $1 billion in losses and cancelled orders since 2022. Moderna aims to align its investments with changing healthcare needs on the continent.

READ ALSO:   China to give COVID vaccine to children as young as 3

Initially, the plan was to produce 500 million vaccine doses annually, focusing on drug substance manufacturing. This delay raises concerns about vaccine access in Kenya and Africa, especially as the country aims to combat COVID-19.

READ ALSO:   Miss World Netherlands quits pageant final to avoid getting COVID vaccine

Follow Us on Facebook – @LadunLiadi; Instagram – @LadunLiadi; Twitter – @LadunLiadi; Youtube – @LadunLiadiTV for updates

LEAVE A REPLY

Please enter your comment!
Please enter your name here